Literature DB >> 15542036

A scrutiny of matrix metalloproteinases in osteoclasts: evidence for heterogeneity and for the presence of MMPs synthesized by other cells.

Thomas L Andersen1, Maria del Carmen Ovejero, Tove Kirkegaard, Thomas Lenhard, Niels T Foged, Jean-Marie Delaissé.   

Abstract

Genetic diseases and knockout mice stress the importance of matrix metalloproteinases (MMPs) in skeletal turnover. Our study aims at clarifying which MMPs are expressed by osteoclasts. Previous analyses of this basic question led to conflicting reports in the literature. In the present study, we used a variety of approaches: PCR, Northern blots, Slot blots, in situ hybridization, and immunohistochemistry. We analyzed osteoclasts in culture as well as osteoclasts in native bone at different locations and compared mouse and rabbit osteoclasts. Osteoclasts express MMP-9 and -14 in all conditions, although to a variable extent, and they are able to synthesize MMP-3, -10, and -12, at least under some circumstances. The induction of a given MMP in osteoclasts is influenced by its environment (e.g., osteoclast culture vs. native bone, and various sites within the same bone) and depends on the species (e.g., mouse vs. rabbit). Osteoclasts show high amounts of MMP-2 and -13 protein presumably made to a large extent by other cells, thereby documenting how proteinases of nonosteoclastic origin may contribute to osteoclast activities and giving insight in why the resorptive activity of purified osteoclasts appears insensitive to MMP inhibitors. Our study shows that the confusion about osteoclastic MMPs in the literature reflects the remarkable ability of osteoclasts to adapt to their environment, as required by the structural or functional diversity of bone tissue. Our observations provide basic information needed for understanding the emerging role of MMPs in controlling cell signaling and bone resorption.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15542036     DOI: 10.1016/j.bone.2004.06.019

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  50 in total

Review 1.  Advances in the understanding of myeloma bone disease and tumour growth.

Authors:  Shmuel Yaccoby
Journal:  Br J Haematol       Date:  2010-03-11       Impact factor: 6.998

2.  A physical mechanism for coupling bone resorption and formation in adult human bone.

Authors:  Thomas Levin Andersen; Teis Esben Sondergaard; Katarzyna Ewa Skorzynska; Frederik Dagnaes-Hansen; Trine Lindhardt Plesner; Ellen Margrethe Hauge; Torben Plesner; Jean-Marie Delaisse
Journal:  Am J Pathol       Date:  2008-12-18       Impact factor: 4.307

Review 3.  Progress in matrix metalloproteinase research.

Authors:  Gillian Murphy; Hideaki Nagase
Journal:  Mol Aspects Med       Date:  2008-05-24

4.  The critical role of the epidermal growth factor receptor in endochondral ossification.

Authors:  Xianrong Zhang; Valerie A Siclari; Shenghui Lan; Ji Zhu; Eiki Koyama; Holly L Dupuis; Motomi Enomoto-Iwamoto; Frank Beier; Ling Qin
Journal:  J Bone Miner Res       Date:  2011-11       Impact factor: 6.741

5.  Differential bone remodeling mechanism in hindlimb unloaded rats and hibernating Daurian ground squirrels: a comparison between artificial and natural disuse.

Authors:  Xuli Gao; Siqi Wang; Jie Zhang; Shuyao Wang; Feiyan Bai; Jing Liang; Jiawei Wu; Huiping Wang; Yunfang Gao; Hui Chang
Journal:  J Comp Physiol B       Date:  2021-05-18       Impact factor: 2.200

6.  Erythropoietin promotes bone formation through EphrinB2/EphB4 signaling.

Authors:  C Li; C Shi; J Kim; Y Chen; S Ni; L Jiang; C Zheng; D Li; J Hou; R S Taichman; H Sun
Journal:  J Dent Res       Date:  2015-01-13       Impact factor: 6.116

7.  Osteoclast-mediated bone resorption is controlled by a compensatory network of secreted and membrane-tethered metalloproteinases.

Authors:  Lingxin Zhu; Yi Tang; Xiao-Yan Li; Evan T Keller; Jingwen Yang; Jung-Sun Cho; Tamar Y Feinberg; Stephen J Weiss
Journal:  Sci Transl Med       Date:  2020-02-05       Impact factor: 17.956

8.  Agonist-regulated cleavage of the extracellular domain of parathyroid hormone receptor type 1.

Authors:  Christoph Klenk; Stefan Schulz; Davide Calebiro; Martin J Lohse
Journal:  J Biol Chem       Date:  2010-01-15       Impact factor: 5.157

9.  The response to oestrogen deprivation of the cartilage collagen degradation marker, CTX-II, is unique compared with other markers of collagen turnover.

Authors:  Anne-Christine Bay-Jensen; Nadine C B Tabassi; Lene V Sondergaard; Thomas L Andersen; Frederik Dagnaes-Hansen; Patrick Garnero; Moustapha Kassem; Jean-Marie Delaissé
Journal:  Arthritis Res Ther       Date:  2009       Impact factor: 5.156

10.  Tetrahydrofurofuran-type lignans inhibit breast cancer-mediated bone destruction by blocking the vicious cycle between cancer cells, osteoblasts and osteoclasts.

Authors:  Ah Young Jun; Hyun-Jeong Kim; Kwang-Kyun Park; Kun Ho Son; Dong Hwa Lee; Mi-Hee Woo; Won-Yoon Chung
Journal:  Invest New Drugs       Date:  2013-05-15       Impact factor: 3.850

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.